PD61-12 CONTRAST ENHANCED ULTRASONOGRAPHY GUIDED PERCUTANEOUS CRYOABLATION FOR CYSTIC RENAL TUMORS

Rong Yang,Huibo Lian,Wei Wang,Hongqian Guo

DOI: https://doi.org/10.1016/j.juro.2018.02.2836

2018-01-01

Abstract:You have accessJournal of UrologyKidney Cancer: Localized: Ablative Therapy1 Apr 2018PD61-12 CONTRAST ENHANCED ULTRASONOGRAPHY GUIDED PERCUTANEOUS CRYOABLATION FOR CYSTIC RENAL TUMORS Rong Yang, Huibo Lian, Wei Wang, and Hongqian Guo Rong YangRong Yang More articles by this author , Huibo LianHuibo Lian More articles by this author , Wei WangWei Wang More articles by this author , and Hongqian GuoHongqian Guo More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2836AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To assess feasibility, safety, and oncologic outcomes of contrast enhanced ultrasonography guided percutaneous cryoablation in the treatment of cystic renal tumors. METHODS We performed a retrospective review of 12 patients with cystic renal tumors who received percutaneous cryoablation under the guidance of contrast enhanced ultrasonography from January 2009 to September 2016. All tumors included were Bosniak III/IV by CT/MR. Four high risk patients were treated under local anesthesia due to severe comorbidities. The median follow-up period was 51 months (range 12 - 93). The ablative effect was evaluated by contrasted enhance CT/MR postoperatively. All conventional perioperative variables, functional and oncological results were analyzed. RESULTS Median diameter of the treated renal tumors was 3.2 cm (range 2.1 - 4.5 cm). Initial ablation success rate was 9/12 (75%). Three incompletely ablated patients experienced a second session of this procedure and achieved complete ablation. After at least 12 months contrast-enhanced CT/MR follow-up after ablation, no patient experienced local tumor recurrence and no patient died of renal tumor. There was no significant difference between the estimated glomerular filtration rate (eGFR) pre- and post-cryoablation. Median change in eGFR 1 year after last cryoablation treatment was -3.6 mL/minute (range -0.5 - -6.3 mL/min). No Major complications (≥ Clavien Dindo Grade 3) developed in these cases. CONCLUSIONS Our initial experience with this technique in cystic renal tumors was favorable with good renal function preservation and oncologic outcomes. It may be a good alternative to partial nephrectomy for selected cystic renal tumors. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1156 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Rong Yang More articles by this author Huibo Lian More articles by this author Wei Wang More articles by this author Hongqian Guo More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...